Glucagon-like peptide: a therapeutic glimmer
- 1 January 1994
- journal article
- Published by Elsevier in The Lancet
- Vol. 343 (8888) , 4-5
- https://doi.org/10.1016/s0140-6736(94)90869-9
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Normalization of fasting hyperglycaemia by exogenous glucagon-like peptide 1 (7-36 amide) in Type 2 (non-insulin-dependent) diabetic patientsDiabetologia, 1993
- Additive insulinotropic effects of exogenous synthetic human gastric inhibitory polypeptide and glucagon-like peptide-1-(7-36) amide infused at near-physiological insulinotropic hormone and glucose concentrations.Journal of Clinical Endocrinology & Metabolism, 1993
- Antidiabetogenic Effect of Glucagon-like Peptide-1 (7–36)amide in Normal Subjects and Patients with Diabetes MellitusNew England Journal of Medicine, 1992
- Proglucagon products in plasma of noninsulin-dependent diabetics and nondiabetic controls in the fasting state and after oral glucose and intravenous arginine.Journal of Clinical Investigation, 1991
- Alterations of plasma immunoreactive glucagon-like peptide-1 behavior in non-insulin-dependent diabeticsDiabetes Research and Clinical Practice, 1990
- Oral Hypoglycemic AgentsNew England Journal of Medicine, 1989
- GLUCAGON-LIKE PEPTIDE-1 7-36: A PHYSIOLOGICAL INCRETIN IN MANPublished by Elsevier ,1987